Stocks Surge to Start the Week, Regeneron's Covid-19 Treatment Disappoints, Returning Aid, Apple Pushing Back Production

  • Af
  • Episode
      203
  • Published
      27. apr. 2020
  • Forlag
0 Anmeldelser
0
Episode
203 of 2182
Længde
46M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Carl Quintanilla, Jim Cramer and David Faber discuss the up start for stocks to kickoff the week. Regeneron's arthritis drug that was seen as a promising treatment for some Covid-19 patients delivered disappointing results in clinical studies. The global total for confirmed coronavirus cases closing in on 3 million.

Adidas reports results and a 93% plunge in first-quarter profit and sales of 19% missing forecasts and warning of a deeper hit to Q2 revenue. Boeing drops it’s Embraer deal saving around $4 billion in much-needed cash. A report says that Apple is pushing back the production of its new iPhone models. Plus, at least 13 of the public companies that received hardship loans said they’ll be returning the money.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...